A Comparison between Lynch Syndrome and Sporadic Colorectal Cancer Survivors’ Satisfaction with their Healthcare Providers by Burton-Chase, Allison M et al.
Dartmouth College 
Dartmouth Digital Commons 
Open Dartmouth: Published works by 
Dartmouth faculty Faculty Work 
1-16-2017 
A Comparison between Lynch Syndrome and Sporadic Colorectal 
Cancer Survivors’ Satisfaction with their Healthcare Providers 
Allison M. Burton-Chase 
Albany College of Pharmacy and Health Sciences 
Wendy M. Parker 
Albany College of Pharmacy and Health Sciences 
Katrina M. Polivka 
University of Texas Health Science Center 
Ellen R. Gritz 
The University of Texas MD Anderson Cancer Center 
Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa 
 Part of the Oncology Commons 
Dartmouth Digital Commons Citation 
Burton-Chase, Allison M.; Parker, Wendy M.; Polivka, Katrina M.; and Gritz, Ellen R., "A Comparison 
between Lynch Syndrome and Sporadic Colorectal Cancer Survivors’ Satisfaction with their Healthcare 
Providers" (2017). Open Dartmouth: Published works by Dartmouth faculty. 682. 
https://digitalcommons.dartmouth.edu/facoa/682 
This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has 
been accepted for inclusion in Open Dartmouth: Published works by Dartmouth faculty by an authorized 




Patients diagnosed with cancer often have increased health-
care needs, which may result in higher expectations of 
care. A greater understanding of predictors of patient 
satisfaction with healthcare providers (HCPs) in an oncol-
ogy setting can provide valuable information to providers 
as well as researchers. There also may be differences 
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Abstract
This study evaluated provider satisfaction in a sample of colorectal cancer (CRC) 
survivors with and without Lynch syndrome (LS). Participants were case–case- matched 
CRC survivors with (n = 75) or without (n = 75) LS (mean age of 55; range: 27–93). 
Participants completed a mailed questionnaire assessing demographics, clinical char-
acteristics, healthcare utilization, psychosocial variables, and provider satisfaction. LS 
CRC survivors reported lower provider satisfaction scores on three subscales of the 
Primary Care Assessment Survey: communication (78.14 vs. 83.96; P < 0.05), inter-
personal treatment (78.58 vs. 85.30; P < 0.05), and knowledge of the patient (60.34 
vs. 69.86; P < 0.01). Among LS CRC survivors, predictors for mean communication 
and trust subscale scores were location of treatment and socioeconomic status. Higher 
mean depression scores also were associated with trust, while social support predicted 
higher satisfaction with communication. Sporadic CRC survivor satisfaction is driven 
largely by age (communication, interpersonal treatment) and patient anxiety (com-
munication), while seeing a provider more often was associated with increased sat-
isfaction with knowledge of the patient. LS CRC survivors reported lower levels of 
provider satisfaction than sporadic CRC survivors. LS survivors who received care 
at The University of Texas MD Anderson Cancer Center, a comprehensive cancer 
center (CCC), reported higher satisfaction than those receiving care at other institu-
tions. Depressive symptoms and socioeconomic status may impact provider satisfaction 
ratings. Exploration of other potential predictors of provider satisfaction should be 
examined in this population. Additionally, further research is needed to examine the 
potential impact of provider satisfaction on adherence to medical recommendations 
in LS CRC survivors, particularly those being treated outside of CCCs.
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between patients with sporadic colorectal cancer and those 
with an inherited syndrome such as Lynch syndrome. 
There is a significant gap in knowledge regarding the 
patient–provider relationship in the oncology literature 
generally and in the Lynch syndrome (LS) population 
specifically. By understanding the predictors of patient 
satisfaction with their HCP for individuals with LS, we 
can better inform community health providers, develop 
more targeted interventions, and ultimately improve screen-
ing and surveillance adherence. This study evaluates sat-
isfaction with HCPs in a matched sample of LS and 
sporadic CRC survivors.
What is LS?
LS is the most common hereditary colon cancer, account-
ing for approximately 3% of all colorectal cancer (CRC) 
cases [1]. LS is characterized by predisposition to several 
cancers, most commonly CRC and endometrial cancer, 
and is caused by germline mutations in DNA mismatch 
repair (MMR) genes, specifically MLH1, MSH2, MSH6, 
PMS2, or in the EPCAM gene [2–7]. These mutations 
can be identified through clinical genetic testing, ideally 
initiated in individuals with cancer [8].
Compared with the general population, MMR mutation 
carriers have a higher lifetime risk for several cancers; 
CRC risk ranges from 20 to 69% for men and 10 to 
52% for women, with risks varying based on mutated 
gene [9–13]. Women with LS also have a 40–60% lifetime 
risk for developing endometrial cancer [2, 3, 8, 14]. 
Individuals with LS are at increased risk for other malig-
nancies, including ovarian, stomach, small bowel, hepa-
tobiliary tract, pancreatic, urinary tract, brain, and skin 
cancers [3, 8, 14]. To mitigate these risks, affected indi-
viduals are advised to follow high- risk surveillance and 
cancer management guidelines [8, 15]. Screening recom-
mendations include annual or biennial colonoscopy initi-
ated at age 20–25 years or 2–5 years younger than the 
earliest known case in the family, which has proven clinical 
benefits, and annual endometrial screening initiated at 
age 30–35 years. In women who have completed child-
bearing, prophylactic endometrial surgery also is recom-
mended [3, 4, 8, 15].
Patient–provider relationships in oncology 
settings
Patients’ satisfaction with their healthcare providers (HCPs) 
has been shown to be positively correlated with adherence 
to screening, surveillance, and treatment [16, 17]. 
Improving adherence to screening for LS individuals is 
particularly important, as their screening regimens are 
demanding and nonadherence can be life- threatening [16, 
17]. One important aspect of patients’ HCP satisfaction 
is the nature of the patient–provider relationship [16–20]. 
Prior research on CRC survivors’ satisfaction with HCP 
has focused on treatment satisfaction or healthcare service 
quality, whereas little is known about characteristics of 
the patient–provider relationship, nor how such charac-
teristics influence patient satisfaction in this population 
[16, 21–23].
For individuals with LS, one critical factor that impacts 
a HCP’s ability to appropriately counsel patients with 
LS is a significant gap in knowledge about genetics and 
LS. HCP not only need to be adequately informed about 
the characteristics of LS, but also need to be able to 
obtain comprehensive medical and family histories, make 
referrals to genetics services, and recommend appropriate 
screening and medical management [4, 24–29]. Data 
from prior studies show that physicians lack knowledge 
in these key areas. One study focusing on gastroenter-
ologists found that when presented with a family history 
consistent with LS, 79% of physicians could identify the 
syndrome, 26% recommended genetic counseling for the 
patient, and only 16% advised appropriate screening [30]. 
In a study that compared knowledge of LS among a 
sample of gastroenterologists and primary care physicians, 
findings showed that gastroenterologists were more likely 
to elicit a family history of colorectal neoplasia (93% 
vs. 63%), implement appropriate screening strategies for 
individuals with LS (73% vs. 50%), and refer a patient 
at risk for LS for genetic testing (72% vs. 57%) [29]. 
However, both groups of physicians demonstrated less- 
than- optimal compliance with recommended screening 
guidelines and with the notification of at- risk relatives 
[29]. HCP knowledge in these areas is key in the LS 
population as research has indicated that simply inform-
ing an individual of his or her mutation status and 
cancer risk may not motivate behavior change, and may, 
in fact, be a barrier to screening if the individual believes 
that they have no control over whether he or she devel-
ops cancer [31–33].
A variety of tools have been used to evaluate patient 
satisfaction with their HCPs in the general population, 
but few have been used in oncology settings [34]. The 
variation in measures and populations used to assess patient 
satisfaction with HCP makes it difficult to compare sat-
isfaction results across studies. Thus, the literature examining 
the patient–provider relationship in oncology, and how it 
relates to satisfaction, remains limited [34]. To more clearly 
articulate the patient–provider relationship in oncology and 
LS populations, we must first understand the predictors 
of patient satisfaction with their HCP [21, 34].
Several studies have identified trust and physician knowl-
edge as important predictors of patient satisfaction with 
HCP in oncology settings [14, 17, 19, 34]. One study, 
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focusing specifically on LS mutation carriers, examined 
barriers and facilitators of screening and management in 
this population [14]. Both trust and physician knowledge 
of family history were interdependent factors that affected 
LS patients’ perception of their HCPs. Study participants 
expressed higher levels of trust when physicians were both 
aware of their family history and recognized the importance 
of high- risk cancer surveillance [14]. These factors also 
influenced participation in recommended screening regimens 
[14]. However, further research is needed to fully examine 
how patient trust can be effectively improved [17].
Other relationship factors, including communication 
and interpersonal behavior, also have been used to assess 
patient satisfaction with HCPs in oncology settings [16, 
18, 20, 35]. One study found that through effective com-
munication, HCPs were able to positively impact health- 
related attitudes and behaviors regarding adherence [18]. 
A particularly salient finding from this study was that 
communication style was the only patient or HCP vari-
able that could both influence screening adherence and 
be taught [18]. In addition to improving patient satisfac-
tion with their HCPs and health behaviors, patient–provider 
communication may be related to patients’ overall quality 
of life [16, 20]. Providers’ interpersonal and socio- 
emotional behaviors, such as empathy, engagement, and 
attentiveness, also appear to be predictors of patients’ 
perception of their HCPs [20].
The aim of this study was to evaluate satisfaction with 
HCPs in a matched sample of LS and sporadic CRC 
survivors. Directly comparing these two populations ena-
bled us to identify factors related to provider satisfaction 
that may be unique to the LS population while also add-
ing to the limited literature on patient satisfaction with 
their providers in an oncology setting.
Materials and Methods
Participants
This study was approved by the Institutional Review Board 
at the University of Texas MD Anderson Cancer Center 
(MD Anderson). Participants were CRC survivors with 
LS or sporadic cancer who were matched on age, sex, 
race/ethnicity, cancer stage, geography, and time since 
diagnosis using a LS case–sporadic case design. Survivors 
with LS were recruited from MD Anderson (n = 33) 
and through social media (n = 42) and had to have 
tested positive for a LS mutation. Sporadic CRC survivors 
were recruited from the tumor registry at MD Anderson 
(n = 75). All participants were 18 years of age or older 
and were able to read and speak English. Patients with 
CRC were limited to those with a diagnosis of CRC 
from 6 months to 5 years prior to enrolling in the study. 
LS participants recruited through MD Anderson were 
screened for eligibility using medical records and those 
recruited through social media were screened by self- 
report over the phone prior to enrolling in the study. 
Using information from their medical records, we excluded 
sporadic CRC patients with a personal or family history 
of familial adenomatous polyposis (FAP) and inflamma-
tory bowel disease, or those who had a first- degree relative 
with CRC.
Data collection methods
Data were collected using a mailed, self- administered 
questionnaire. Eligible survivors received a packet contain-
ing an introductory letter, questionnaire, and a self- 
addressed stamped return envelope. Nonrespondents 
received an identical follow- up mailing at 3 weeks after 
the initial mailing and a follow- up reminder phone call 
at 6 weeks with the option to complete the questionnaire 
over the phone. Those who completed the questionnaire 
received a $10 gift card as compensation.
Study measures
Demographic data were obtained through self- report. 
Medical data were obtained through medical records and 
self- report.
The location of treatment for each patient was noted 
in an open- ended question and then coded as an NCI- 
designated comprehensive cancer center (CCC) or other 
healthcare institution. All individuals seen at a CCC received 
care at MD Anderson. Healthcare utilization was measured 
using a 4- item scale developed by the Stanford Chronic 
Disease Self- Management Study [36]. This measure quanti-
fies physician, emergency room, and hospital visits.
The 20- item Center for Epidemiologic Studies 
Depression (CES- D) scale measured depressive symptoms 
[37]. A clinical psychologist was available for referral for 
individuals who were identified as showing high levels 
of depressive symptomatology. Anxiety was measured 
using the State- Trait Anxiety Inventory (STAI). Both the 
CES- D and STAI are widely used in clinical and medical 
populations and have good internal consistency and reli-
ability [37, 38]. Social support and satisfaction with social 
support were assessed using a scale by Krause and 
Borawski- Clark [39].
We used four scales from the Primary Care Assessment 
Survey (PCAS) to measure the patient’s relationship with the 
treating provider for our outcome, including communication, 
interpersonal treatment, patient trust, and provider’s knowl-
edge of the patient (comprehensive) [40–42]. The instructions 
for the PCAS ask the patient to “think about the one health-
care provider who is most involved in coordinating his or 
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her care” when responding to the questions. The measure 
does not specifically ask for provider specialties. In prior 
research, these scales have correlated well with outcomes of 
care such as adherence and satisfaction [40–42].
Statistical analysis
Bivariate differences were evaluated between LS and 
sporadic survivors on known or expected factors related 
to provider satisfaction using chi- square, and completed 
with SAS version 9.3 [43]. Regression models were esti-
mated separately for LS and sporadic survivors to inde-
pendently evaluate the factors that predicted provider 
satisfaction. Distinct models were estimated for each of 
the four PCAS subscales (communication, interpersonal 
treatment, trust, and provider’s knowledge of the patient) 
in each group.
Results
Demographic and bivariate analysis
From the overall sample of 75 LS CRC and 75 sporadic 
CRC survivors, we excluded seven who were missing at 
least one component of our outcome measure, the PCAS 
scale. Our analytic sample for this study included 73 LS 
CRC and 70 sporadic CRC survivors. The average age of 
participants was in their early 50s with a mean age of 
52.6 years for patients with LS and 54.1 for patients with 
sporadic cancer, with more females than males (54.9% and 
57.1%, respectively) and LS more likely to be married 
(83.6% and 77.1%, respectively, for LS versus sporadic). 
Demographic characteristics can be seen in Table 1. Due 
to the matching of LS and sporadic cases, there were no 
significant demographic differences between groups. We 
Table 1. Demographics n (%) [95% confidence interval].
Characteristic LS (n = 73) Sporadic (n = 70) P- value
















































































Not all percentages and totals add up due to missing data.
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also assessed differences between the LS CRC survivors 
who were recruited through MD Anderson and those 
recruited through social media and found no significant 
differences.
As illustrated in Table 2, healthcare utilization was 
similar between the LS and sporadic CRC groups. Within 
the last 6 months, most had seen their doctors just under 
four times and had less than one emergency room visit 
or hospital admission. There were no significant differ-
ences between LS and sporadic CRC survivors on any 
psychosocial measures (CES- D, Trait, or State anxiety 
scales). Satisfaction with social support and family support 
showed no differences between the two groups. There 
was a significant difference in friend support, with LS 
CRC survivors scoring lower than sporadic CRC survivors 
(LS = 23.647; sporadic = 25.706; P = 0.03). There were 
no differences on any of these variables between the two 
recruitment sources for LS survivors.
Compared with sporadic CRC survivors, LS survivors 
reported lower mean provider satisfaction scores on three 
of the PCAS subscales: communication (78.14 vs. 83.96; 
P = 0.05), interpersonal treatment (78.58 vs. 85.30; 
P = 0.02), and physician’s knowledge of the patient (60.34 
vs. 69.86; P = 0.01). There was no statistical difference 
in provider trust between the two groups.
Regression analysis
Tables 3 and 4 show the linear regression models for 
factors for each of the four PCAS subscales for LS and 
sporadic patients, respectively. Among LS CRC survivors, 
communication and trust subscales showed similar pat-
terns of predictors. Having more education or having 
financial challenges was associated with increased mean 
scores for both communication and trust, while being 
treated outside of a CCC was associated with lower scores. 
Table 2. Healthcare experiences, social support, and patient satisfaction mean scores n (%) [95% confidence interval].
Mean/(SD) LS (n = 73) Sporadic (n = 70) P- value
Location of treatment Comprehensive cancer centers 33 (45.2%) 
[0.335–0.569]
70 (100%) ***(P < 0.001)
Noncomprehensive cancer centers 40 (54.8%) 
[0.431–0.665]
0 (0%)
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Table 3. Regression model for patients with LS (n = 73).
Variable
Parameter estimate (SE)
Communication (r2 = 0.458) Interpersonal (r2 = 0.374) Trust (r2 = 0.459) Comprehensive (r2 = 0.384)
Intercept 24.737 (23.710) 37.229 (27.569) 44.851 (21.149) 0.499 (30.675)
Age 0.304 (0.225) 0.245 (0.262) 0.184 (0.201) 0.365 (0.291)
Female 0.415 (4.382) −0.835 (5.096) −3.204 (3.909) −2.248 (5.670)
Not Married −11.130 (6.708) −13.511 (7.799) −9.746 (5.983) −9.131 (8.678)
Child −1.782 (6.013) −1.170 (6.991) 1.527 (5.363) 6.270 (7.779)
Non- white 7.453 (7.914) 3.210 (9.202) −2.095 (7.059) 13.198 (10.239)
<College degree 7.293 (5.306) 4.005 (6.169) 6.882 (4.733) 6.443 (6.864)
Postgrad degree 11.879* (5.124) 7.205 (5.958) 10.156* (4.570) 11.956 (6.629)
Unemployed 0.750 (4.848) −0.465 (5.637) −4.079 (4.324) −4.071 (6.272)
Financial difficulty 13.025* (6.513) 6.256 (7.573) 13.145* (5.810) 11.397 (8.426)
Moderate financial difficulty 2.874 (4.546) 1.415 (5.286) 5.564 (4.055) 8.328 (5.882)
# Dr. visits 0.253 (0.605) 0.589 (0.703) 0.250 (0.540) −0.149 (0.783)
# ER visits −3.996 (4.264) −3.816 (4.958) −4.133 (3.804) 0.823 (5.717)
# Hospital stays 6.778 (8.287) 11.628 (9.636) 6.813 (7.392) 15.531 (10.722)
# Hospital nights −0.050 (1.771) −1.141 (2.059) −0.543 (1.580) −3.236 (2.291)
CES- D −0.616 (0.323) −0.664 (0.376) −0.843** (0.288) −0.620 (0.418)
Krause 0.192 (0.652) −0.330 (0.758) −0.039 (0.582) 0.982 (0.843)
Lubben family 0.871* (0.410) 0.810 (0.477) 0.698 (0.366) 0.959 (0.530)
Lubben friend 0.166 (0.410) 0.191 (0.477) 0.255 (0.366) 0.166 (0.530)
Trait 0.125 (0.131) 0.161 (0.152) 0.022 (0.117) −0.004 (0.169)
State −0.127 (0.218) 0.092 (0.253) 0.135 (0.194) 0.010 (0.282)
Non- CCC −11.361** (4.061) −7.709 (4.722) −8.786* (3.622) −4.286 (5.254)
*P < 0.05.
**P < 0.01.
Table 4. Regression model for sporadic patients (n = 70).
Variable
Parameter estimate (SE)
Communication (R2 = 0.283) Interpersonal (R2 = 0.312) Trust (R2 = 0.152) Comprehensive (R2 = 0.224)
Intercept 116.633 (29.030) 107.639 (26.328) 96.695** (24.280) 34.036 (36.081)
Age −0.588* (0.266) −0.545* (0.242) −0.389 (0.223) −0.028 (0.331)
Female −8.318 (5.052) −6.081 (4.582) −2.412 (4.225) −1.658 (6.279)
Not Married 6.170 (7.008) 2.551 (6.356) 0.995 (5.861) 1.110 (8.710)
Child 6.497 (7.235) 7.081 (6.562) 3.059 (6.051) 7.171 (8.992)
Non- white −2.661 (10.098) 4.706 (9.158) 0.300 (8.445) 7.068 (12.550)
< college degree 4.865 (5.492) 3.323 (4.981) 2.909 (4.593) 10.420 (6.826)
Postgrad degree −3.095 (6.873) −4.464 (6.232) 1.415 (5.748) 1.454 (8.541)
Unemployed 3.646 (5.603) 5.826 (5.081) 3.807 (4.686) 3.804 (6.964)
Financial difficulty 1.214 (7.356) 1.613 (6.671) −0.571 (6.152) −3.804 (9.143)
Moderate financial difficulty 0.647 (5.954) 3.631 (5.340) 2.198 (4.980) −5.389 (7.400)
# Dr. visits 1.705 (0.968) 1.339 (0.878) 0.567 (0.810) 2.451* (1.203) 
# ER visits −3.907 (4.675) −4.061 (4.240) −2.969 (3.910) 2.101 (5.765)
# hospital stays −0.467 (10.512) 3.783 (9.534) 2.485 (8.792) −9.122 (13.066)
# hospital nights 0.602 (1.779) 0.283 (1.622) 0.052 (1.496) 1.845 (2.223)
CES- D 0.315 (0.388) 0.187 (0.351) −0.033 (0.324) −0.091 (0.482)
Krause 0.867 (0.949) 1.365 (0.861) 0.544 (0.794) −0.240 (1.179)
Lubben family 0.182 (0.433) 0.183 (0.393) 0.054 (0.362) −0.119 (0.538)
Lubben friend −0.525 (0.494) −0.328 (0.448) −0.182 (0.413) 0.773 (0.614)
Trait 0.058 (0.212) −0.034 (0.193) 0.062 (0.178) 0.106 (0.264)
State −0.570* (0.286) −0.448 (0.259) −0.249 (0.239) −0.082 (0.355)
*P < 0.05.
**P < 0.01.
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Being treated at healthcare institution that was not a CCC 
was a predictor for lower mean scores on communication 
(−11.36; P < 0.01) and trust (−8.79; P < 0.05) subscales. 
Higher mean depression scores were associated with lower 
mean scores on the trust subscale (−0.84; P < 0.01). 
Higher mean scores on family support were associated 
with higher communication satisfaction scores (0.87; 
P < 0.05). There were no significant predictors for the 
interpersonal or comprehensive subscale measures.
Regression results for the sporadic CRC survivors differed 
from those of the LS survivors. There were no specific pre-
dictors for the trust subscale. Age was negatively associated 
with the communication and interpersonal subscale scores 
for sporadic survivors, indicating that as a patient gets older, 
he or she is less satisfied with providers in terms of com-
munication and overall interaction (communication: −0.59; 
P < 0.05; interpersonal: −0.55; P < 0.05). Lower mean State 
anxiety scores were associated with higher satisfaction scores 
for these survivors (−0.57; P < 0.05). Increased utilization 
was associated with higher satisfaction with the comprehensive 
aspects of provider treatment (2.45; P < 0.05).
Discussion
The goal of this study was to assess patient satisfaction 
with their healthcare providers in a sample of CRC sur-
vivors both with and without LS. Specifically, we were 
interested in comparing these two groups and then assess-
ing factors drawn from the literature that impact these 
ratings of HCP satisfaction. Having a better understanding 
of these complex patient–provider relationships can both 
inform community health providers and assist in the 
development of future interventions.
In our study, LS CRC survivors reported lower levels 
of satisfaction with their healthcare providers than sporadic 
CRC survivors, especially as related to communication, 
interpersonal interactions, and knowledge of the patient 
as a person. There were no differences between the two 
groups in our study in terms of ratings of provider trust. 
LS CRC survivors who received care at CCCs reported 
higher satisfaction when compared to those receiving care 
at other institutions, specifically in terms of communica-
tion and trust. Depressive symptoms and socioeconomic 
variables also impacted ratings of satisfaction with provider 
communication and trust in our LS population. Our find-
ing regarding higher levels of education being associated 
with higher provider satisfaction is contrary to what has 
been reported in the general oncology literature assessing 
overall satisfaction with health care. Specifically, higher 
education has been associated with lower levels of satisfac-
tion [44, 45]. However, we also found evidence supporting 
increased provider satisfaction for individuals who self- 
reported financial concerns. Given that specific qualities 
such as physician skill, provider communication, and phy-
sician contact with patients are key components of overall 
satisfaction with health care, our contradictory results for 
these socioeconomic variables in the LS population merit 
additional research [44, 45]. While we found no significant 
predictors for the interpersonal or comprehensive subscale 
measures, prior research with cancer survivors has shown 
that the comprehensive aspects of the provider relationship 
(feeling like the provider knows you as a whole person) 
as well as higher levels of perceived patient- centeredness 
are key factors in overall provider satisfaction [19]. One 
of the primary reasons that we were interested in examin-
ing factors that predict provider satisfaction in the LS 
population is because we know that provider recommen-
dations and provider satisfaction play key roles in patient 
adherence to screening and surveillance guidelines and that 
nonadherence can be life- threatening [16–20]. While we 
have identified some factors that influence provider sat-
isfaction in LS CRC survivors, further research is needed 
in this unique population, particularly in relation to inter-
personal and comprehensive aspects of care.
For sporadic CRC survivors, older age, higher anxiety, 
and healthcare utilization impacted healthcare provider 
satisfaction. Specifically, older survivors reported lower 
levels of satisfaction with respect to provider communica-
tion and the interpersonal aspects of their care. CRC 
survivors who reported higher anxiety also reported lower 
levels of satisfaction with patient–provider communication. 
Additionally, the more often a patient sees a HCP, the 
more satisfied he or she is with how much knowledge 
that HCP has about him or her as a person. This finding 
aligns with prior research showing that cancer survivors 
who are able to ask their providers questions and have 
their providers explain things in a way they can under-
stand are more satisfied with their care [46].
Taken together, our study findings provide information 
that is relevant to both clinicians and researchers in regard 
to factors that influence provider satisfaction in CRC 
survivors both with and without LS and contribute to 
the small body of literature that exists on provider sat-
isfaction in an oncology setting. We found evidence to 
suggest that patients with LS, particularly those who are 
being treated outside of CCCs, are less satisfied with 
their HCP than sporadic CRC survivors; however, many 
of the factors that we hypothesized might predict provider 
satisfaction in this population were not significant in our 
regression models. Specifically, we expected that both 
healthcare experiences and psychosocial factors would 
have a greater impact on patient satisfaction with their 
HCPs. While some of these variables were significant in 
our models, the extent was less than expected based on 
the literature. Despite these important conclusions and 
comparisons between LS and sporadic CRC survivors, 
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we recognize that our study is limited by the small sample 
sizes of both groups as well as the potential bias in 
recruitment from two different pools of patients with 
LS. Recruitment for this hard- to- reach hereditary cancer 
population as well as case–case matching was painstak-
ingly undertaken to ensure high- quality data. Additionally, 
the control sample is drawn from one CCC, limiting 
our ability to assess location of care in the sporadic CRC 
population. One other study limitation is the lack of 
data on provider specialties as participants were asked 
to rate the provider most involved in coordinating his/
her care, but were not asked to identify specialty areas. 
This data should be collected in future studies. Given 
the above- mentioned factors, the results from this study 
may not be generalizable to all CRC survivors with or 
without LS.
We believe that the findings from this study contribute 
to the scant literature on patient satisfaction with their 
HCPs both in the oncology literature generally and in 
the LS population specifically. We discovered a gap in 
patient satisfaction with their HCPs in these two patient 
populations that had not previously been demonstrated 
in the literature and also identified predictors of provider 
satisfaction that are unique to each of these CRC survivor 
populations. We also documented that location of care 
is a key factor in determining patient satisfaction with 
their HCPs for LS CRC survivors. While these findings 
can aid HCPs as well as researchers, we believe that 
further research is needed in a larger sample as well as 
with qualitative data to more closely examine character-
istics of the patient–provider relationship and to identify 
additional predictors of patient satisfaction with HCPs. 
This work also needs to be expanded to assess the poten-
tial impact of patient satisfaction with their HCPs on 
adherence to medical management recommendations in 
LS CRC survivors, particularly those receiving care outside 
of CCCs.
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